2026 online sources for Chloroquine generic purchases - in Australia

Overview brief

This page brings together concise, Australia-centred information about chloroquine: what it is used for, common dosing patterns, safety metric monitoring, routes to obtain it locally, and a quick look at typical costs. Use the navigation to jump to dosingliterature review treatment side effects, or see how it is regulated and supplied located in Australia.

• Active moiety: chloroquine, usually supplied as chloroquine phosphate; many dosing recommendations refer to chloroquine base equivalent.
• Common tablet strengths: 250 mg and 500 mg of chloroquine phosphate. A 500 mg tablet equates to roughly 300 mg chloroquine base.
• Main functions: antimalarial agent (prevention and treatment where the infecting strain is chloroquine-sensitive) and adjunctive therapy for tissue-invasive amebiasis. It is not a recommended antiviral for illnesses such as COVID-19.
• Availability: internationally known as Aralen among other brands, but in Australia generic products and occasional special-order supplies are more typical; stock can vary between pharmacies and travel clinics.

For complementary medicines and estimated retail prices, see Cost comparison and other course options. For safety checks and follow-up, go to Observation and safety.

Symptoms and signs

In Australia, clinicians may prescribe chloroquine for the following situations when appropriate:

• Malaria: prevention and treatment of infections caused by Plasmodium vivax, P. malariae, P. ovale and P. falciparum strains known to be chloroquine sensitive.
• Amoebic invasion beyond the intestine: used for tissue-invasive disease as part of a combined treatment strategy alongside luminal amebicides.

Important: chloroquine resistance in P. falciparum is widespread globally, so other antimalarial options are commonly preferred depending on the travel destination. Seek destination-specific advice from a travel medicine clinic.

The proper way to take chloroquine

• Adhere to the prescription to the letter. Do not alter the dosing or stop treatment without consulting the prescriber.
• Swallow tablets with a glass of water; taking them with food or milk may reduce stomach upset.
• For weekly prevention regimens, take the dose on the same weekday each week to maintain adherence. For twice-daily schedules, anchor doses to meals such as breakfast and dinner.
• Complete the full course even if symptoms resolve early to reduce the chance of relapse.
• If a dose is forgotten, take it as soon as you remember, unless the next dose is due soon. Do not offset a not taking the dose by taking twice the amount.

See specific regimens in Scheduling of medication doses, and revisit thoroughly relative contraclues and preventive precautions ahead of starting therapy.

Dose and schedules

Doses in many clinical sources are given as chloroquine base. For conversion: 500 mg chloroquine phosphate corresponds to approximately 300 mg chloroquine base. Pediatric doses are calculated by body weight, and dose adjustments may be needed for renal or hepatic impairment.

Suppression of malaria via prophylactic treatment

• Adults: 500 mg chloroquine phosphate (around 300 mg base) once weekly on a consistent weekday.
• Children: approximately 5 mg/kg of chloroquine base once weekly, not exceeding the adult dose.
• Timing: begin 1 to 2 weeks prior to travel to an endemic area. If starting late, an adult loading regimen of 1 g chloroquine phosphate (about 600 mg base) split into two doses 6 hours apart may be used; children may receive 10 mg/kg base divided into two doses 6 hours apart. Continue weekly while exposed and for 8 weeks after leaving the area.

Quick treatment for acute malaria

• Adults (example regimen): 1 g chloroquine phosphate (roughly 600 mg base) initially, then 6 to 8 hours later 500 mg (about 300 mg base), followed by 500 mg once daily for the next two days. Total over three days typically equals 2.5 g phosphate (about 1.five grams make up the base
• The little crowd (weight-based base dosing):
  • First dose: 10 mg/kg (maximum about 600 mg base).
  • The second dose is to be given after six hours at 5 mg/kg, with a cap of roughly 300 mg base.
  • Third dose (24 hours after first): 5 mg/kg.
  • Fourth dose (36 hours after first): 5 mg/kg.
• When treating P. vivax or P ovale, prescribe an 8-aminoquinoline (for example primaquine or tafenoquine where appropriate) to eradicate liver hypnozoites after confirming suitability (for example G6PD testing).

Extraintestinal amoebic disease

• Adults: a common approach is 1 g chloroquine phosphate (about 600 mg base) daily for 2 days, then 500 mg (about 300 mg base) daily for a minimum of 2 to 3 weeks. Combine with a luminal agent to clear intestinal carriage.

These examples are illustrative and not exhaustive. Always follow local clinical guidelines plus the product information supplied with the medicine. For follow-up recommendations, see Safety via system monitoring.

Go return to page top

Cautions, conditions that rule out this therapy, and protective protocols

• Previous severe allergic reaction to chloroquine or related 4-aminoquinolines.
• Existing retinal or macular disease: avoid unless specialist assessment and system monitoring are arranged.
• Skin conditions such as psoriasis or metabolic conditions like porphyria may worsen with chloroquine; obtain specialist input.
• Seizure disorders or other factors that increase seizure risk: use caution, particularly with concomitant drugs that lower seizure threshold.
• Cardiac risk: chloroquine can prolong the QT interval. Be cautious if there is known QT prolongation, electrolyte disturbance, or concurrent use of other QT-prolonging medications.
• Significant renal or liver dysfunction: dose adjustments or close metric monitoring may be required.
• When planning radical cure with 8-aminoquinolinesplease check the details. G6PD status first.
• From conception to lactation: chloroquine can be used in pregnancy for malaria telltale signs when benefits outweigh risks; individualised advice is essential.
• Keep all medication secure; even a small amount swallowed by a child can be harmful.

Return to the previous page top

Potential potential user the dynamic of social contacts drive engagement and learning. among medications

The following social conversational exchanges influence perceptions and decisions. are examples, not a complete list. Always provide a current list of your medicines and supplements to the prescriber and pharmacist.

• Antacids and adsorbents (for example aluminium or magnesium antacids, kaolin): may reduce chloroquine absorption; separate dosing by about four hours.
• Other drugs that prolong QT interval (for example certain macrolide antibiotics, some fluoroquinolones, selected antipsychotics, methadone, and some antiarrhythmics): combined use increases arrhythmia risk.
• Digitalis glycoside digoxin: chloroquine may raise digoxin levels; monitor and adjust therapy as needed.
• The drug known as cyclosporine: levels of cyclosporine can be affected by chloroquine.
• Insulin and oral hypoglycemics: risk of enhanced hypoglycemia; monitor blood glucose closely.
• Cimetidine available as prescribed medication may increase chloroquine concentrations; rifampicin can reduce them.
• Some antiepileptic drugs and mefloquine: global teams rely on robust the networked exchange of ideass. can affect seizure threshold or drug levels; specialist advice is recommended for combined use.

Discuss your full medication list with a clinician before starting chloroquine. For recommended access to storage space determines how quickly items can be retrieved. procedures, see the access to storage space determines how quickly items can be retrieved. guidelines. Cloud temporary storage helps stage tasks before final processing..

Move to top

Safety through continuous oversight

• Eyesight: report any new blurring, difficulty reading, or changes in peripheral vision promptly. Long-term or high-dose use may require ophthalmology review.
• Blood tests: for extended courses clinicians may monitor full blood count and liver function, and assess for neuromuscular symptoms such as weakness.
• Activities: avoid driving or operating machinery if you experience dizziness, lightheadedness or visual disturbances.
• Discuss alcohol, tobacco and caffeine use with your clinician for potential effects on harmful effects or interacting with otherss can be viewed as exchanges of relevant information..
• Pregnancy planning: early discussion with a clinician is advised to choose the safest antimalarial if pregnancy is planned or suspected.

See Possible unwanted effects for symptoms that require urgent attention and Dose regimen and schedule for how regimens affect vigilant monitoring.

Move back to top

Likely incidental outcomes

Short courses are commonly tolerated, but risk of adverse events increases with higher cumulative doses or prolonged therapy. If you experience severe or worrying symptoms, contact a healthcare professional now.

Seek urgent medical attention if you develop

• Sudden loss of vision, severe eye pain, or a major change in sight.
• Very fast or irregular heartbeat, fainting, severe lightheadedness, or chest pain.
• Signs of bleeding such as black stools, blood in urine or stool, unusual bruising, or pinpoint red spots on the skin.
• Seizure occurrences, marked confusion or severe mood changes, ringing in the ears or hearing loss.
• High fever, sore throat, persistent cough, worsening muscle weakness, or pain on urination or flank pain.

Overdose tragedy

Chloroquine experienced an overdose is a medical emergency. Symptoms may include drowsiness, agitation, recurring headache, severe cardiovascular toxicity and collapse. If you believe someone has experienced an overdosed, call emergency services right away.

Typical or mild effects

• Pain of the head
• Nausea and vomiting episodes
• Stools that are loose
• Reduced urge to eat
• Itching (more common in some ethnic groups)
• Belly pain or cramping
• Difficulty focusing or temporary visual blurring

Uncommon reactions

• Rash or skin eruptions
• Blue-black pigmentation of skin, nails or oral mucosa
• Changes to hair color or increased hair loss

If any adverse effect is persistent, severe, or not mentioned here, contact your healthcare provider for advice.

Scroll to top

Cold the storage of files is essential for data management.

• Keep out of sight and reach of children; even a small accidental ingestion by a child can be dangerous.
• Store at ambient room temperature in its original container, away from direct sunlight, heat and moisture.
• Do not freeze. Avoid storing in bathrooms or in vehicles where temperature and humidity fluctuate.
• Use the original blister pack or bottle until the time of use. Bring back unused or expired medications to a pharmacy for safe disposal.

For safety observation and tracking tips see Safety with active the act of monitoring.

Move to top

Other options and custom pricing comparison (AUD)

Choice of an antimalarial or amebicide depends on travel destination, species and resistance patterns, medical history, pregnancy status and tolerability. The price bands below are indicative Australian retail figures and may change with time, pharmacy, pack size and PBS subsidies.

Well-known different substitutes used for malaria

• Atovaquone/proguanil 250/100 mg (Malarone and generics): often recommended where chloroquine resistance is present. Approx. AUD 60 to 120 for a 12-tablet pack.
• Doxycycline 100 mg: commonly used for prophylaxis. Approx. AUD 10 to 25 depending on pack size and pharmacy.
• Mefloquine 250 mg: weekly prophylaxis option for some travellers. Approx. AUD 40 to 90 for an 8-tablet supply.
• Artemisinin-based combination therapies (for example artemether/lumefantrine 20/120 mg): used for treatment courses rather than prevention. Approx. AUD 40 to 100 per treatment course.
• Tafenoquine: used for radical cure of P. vivax and in some settings for prophylaxis for eligible adults with normal G6PD; prices are variable and may range widely depending on subsidy.
• Chloroquine phosphate 500 mg: due to limited role and patchy supply, when available retail cost can be roughly AUD 20 to 50 for 10 to 20 tablets.
• Hydroxychloroquine 200 mg: related 4-aminoquinoline used mainly in rheumatology; occasional crossover in discussion of ill effects or supply. Private purchase costs may be around AUD 60 to 100 for 60 tablets where not subsidised.

Secondary options for amebiasis

• Metronidazole: widely used for tissue-active therapy; typically followed by a luminal agent. Approx. AUD 10 to 20 for a standard course.
• Tinidazole: may offer shorter courses than metronidazole in some regimens. Approx. AUD 8 to 15 for a single high-dose treatment.
• Paromomycin (luminal agent): availability can be limited and may require special order; approximate cost AUD 80 to 200 depending on source.
• Iodoquinol or diloxanide furoate: luminal agents with variable supply and pricing model under special access arrangements.

Confer with a professional a travel medicine specialist or infectious disease clinician to match the most appropriate medicine to your itinerary and individual health profile.

Take me back the apex

Legal rights and access in Australia

• Prescription status: chloroquine is classified as a Schedule 4 (S4) prescription-only medicine in Australia; a valid prescription from an Australian-registered prescriber is required for supply.
• TGA regulation: products are subject to Therapeutic Goods Administration oversight; unregistered products may sometimes be supplied via authorised pathways such as the Special Access Scheme or Authorised Prescriber arrangements.
• PBS and subsidy: a number of antimalarials are listed on the Pharmaceutical Benefits Scheme for certain manifestations. Chloroquine is less commonly used and may not be PBS-subsidised for many malaria-related uses.
• Personal importation: the TGA Personal Importation Scheme allows individuals to import limited quantities for personal use (for example a few months supply per shipment); local rules and documentation requirements apply, and a prescription is usually necessary.
• Local rules: S4 controls are guided by the national Poisons Standard, but state and territory procedures for dispensing and collection may vary. Pharmacies commonly require a current prescription and identification on collection.
• Travel medicine services: because of widespread resistance, travel clinics may recommend a second possibility antimalarials based on destination-specific risk assessments; seek advice well before departure.

Always follow current Australian clinical guidance when prescribing or using chloroquine. For another way forward options and cost projections see Marketplace price comparison with a different route options.

Go to the peak of the page